Share Your Feedback

Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likely Extremely likely
(Optional)
JNJ

Johnson & Johnson

JNJ Health technology
$481.8B
Market Cap

Shariah Analysis

Passed

Business Cash Liabilities

Based on AAOIFI screening standards, Johnson & Johnson appears to be Passed.

Business Activity
FYE 2024
Non-Permissible Income (<5%) 1.50%
Non-Permissible
$1.3K
Total Income
$90.2K
Revenue Breakdown
Innovative Medicine
$57K
MedTech
$31.9K
Interest income
Non-Operating
$1.3K
Non-Compliant: $1.3K
Israel involvement

Israel Involvement

Total Funded
$137.3M
Employees in Israel
201-500
Companies Funded
3
Overview

Johnson & Johnson Inc engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company's segments include consumer, pharmaceutical, and medical devices. The company's primary focus is on products related to human health and wellbeing.In Israel, Johnson & Johnson has four sub-companies. The company's operations in Israel span research and development, as well as commercial activities in the healthcare sector.

Israeli Portfolio
V-Wave
V-Wave

Miniature Shunt for Treating Congestive Heart Failure

Raised: $132.5M 11-50
Omrix Biopharmaceuticals
Omrix Biopharmaceuticals

Human Plasma Derived Products

Raised: $4.84M 201-500
Biosense Webster
Biosense Webster

Diagnosis and Treatment of Cardiac Arrhythmias

500+
Affiliated Organizations
FutuRx
FutuRx
Investor
Johnson & Johnson Innovation
Johnson & Johnson Innovation
Investor

Market Data

Exchange NYSE NYSE
Currency USD
Country United States
Last Updated 2025-12-19

Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.

Advertisement Banner